![](/img/cover-not-exists.png)
PIN29 COST OF THERAPY FORARV NAIVE HIV-INFECTED PATIENTS: FOSAMPRENAVIR / RITONAVIR VERSUS NELFINAVIR
WC Lee, M Hoffmann, J Stephens, K Williams, LZ Liu, CL PashosVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)62812-4
File:
PDF, 63 KB
english, 2005